ID   BS
AC   CVCL_QW64
DR   Wikidata; Q54798325
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=14671638;
RX   PubMed=27467674;
CC   Doubling time: 24-48 hours (PubMed=27467674).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12D
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=14671638; DOI=10.1038/sj.leu.2403236;
RA   Drexler, Hans Gunther
RA   Quentmeier, Hilmar
RA   MacLeod, Roderick A.F.
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   MLL gene alterations.";
RL   Leukemia 18:227-232(2004).
//
RX   PubMed=27467674; DOI=10.3109/10428199109068092;
RA   Katz, Fay
RA   Gibbons, Barbara
RA   Chessells, Judith
RT   "An early B cell line with a variant 11;19 translocation.";
RL   Leuk. Lymphoma 4:397-404(1991).
//